A

Assertio Holdings
D

ASRT

0.93610
USD
-0.02
(-2.43%)
Market Closed
Volume
12,949
EPS
-0
Div Yield
-
P/E
-2
Market Cap
89,376,769
OverviewSignalsIdeasNews
Related Instruments
    A
    ACST
    0
    (0%)
    0.000000 USD
    A
    ALLK
    -0.02000
    (-1.71%)
    1.15000 USD
    A
    AMRN
    -0.01500
    (-2.88%)
    0.50510 USD
    G
    GLPG
    -1.130
    (-4.05%)
    26.780 USD
    O
    OPRX
    -0.23000
    (-5.68%)
    3.82000 USD
    O
    OPTN
    -0.00500
    (-1.10%)
    0.45000 USD
    S
    SNDX
    -0.955
    (-5.69%)
    15.825 USD
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    More
News

Title: Assertio Holdings

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.